Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.09. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
24.09. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | 4 | SGX Company Announcements | ||
03.09. | RAFFLES MEDICAL GROUP LTD: REPL::EMPLOYEE STOCK OPTION/ SHARE SCHEME::EMPLOYEE STOCK OPTION/SHARE SCHEME | 1 | SGX Company Announcements | ||
02.09. | RAFFLES MEDICAL GROUP LTD: EMPLOYEE STOCK OPTION/ SHARE SCHEME::GRANT OF AWARDS/SHARE OPTIONS PURSUANT TO THE RMG (2020) PERFORMANCE SHARE PLAN/SHARE OPTION SCHEME | 1 | SGX Company Announcements | ||
02.09. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
02.09. | RAFFLES MEDICAL GROUP LTD: EMPLOYEE STOCK OPTION/ SHARE SCHEME::EMPLOYEE STOCK OPTION/SHARE SCHEME | 1 | SGX Company Announcements | ||
13.08. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | - | SGX Company Announcements | ||
07.08. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
05.08. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
01.08. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
29.07. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
29.07. | RAFFLES MEDICAL GROUP LTD: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::HALF YEARLY RESULTS | 1 | SGX Company Announcements | ||
27.06. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | - | SGX Company Announcements | ||
24.06. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
21.06. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
18.06. | RAFFLES MEDICAL GROUP LTD: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::NOTIFICATION OF RESULTS RELEASE | 5 | SGX Company Announcements | ||
18.06. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
13.06. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
11.06. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 2 | SGX Company Announcements | ||
06.06. | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 51,48 | +0,27 % | Siemens Healthineers Aktie: Kursrückgang trotz positiver Prognosen | Die Siemens Healthineers-Aktie verzeichnete am Handelstag einen Rückgang von 1,1 Prozent auf 51,38 Euro an der XETRA-Börse. Trotz des aktuellen Kursrückgangs liegt die Aktie immer noch 12,70 Prozent... ► Artikel lesen | |
FRESENIUS | 33,430 | -0,57 % | DAX höher, Gold weiter stark: SAP, Traton, Deutsche Börse, VW, BMW, Fresenius, Rheinmetall ... | Der DAX hat zum Wochenstart knapp unterhalb der 20.000-Punkte-Marke Luft geholt. Er ging am Ende mit einem Minus von einem Prozent auf 19.461,19 Zählern aus dem Handel. Am Donnerstag hatte der deutsche... ► Artikel lesen | |
GERRESHEIMER | 83,85 | +1,33 % | Neue 11,75% Aktienanleihe mit Barriere auf Gerresheimer in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC6CSJ6/ WKN VC6CSJ) mit Barriere auf die Aktie von Gerresheimer... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 39,030 | +0,67 % | Minimale Kursveränderung bei FMC-Aktie (57,3308 €) | Die Wertschätzung für das Wertpapier von FMC hat sich an der Börse am Mittwoch kaum geändert. Das Wertpapier notiert derzeit bei 61,81 US-Dollar. Der heutige Börsentag brachte bislang wenig Kursbewegung... ► Artikel lesen | |
CARL ZEISS MEDITEC | 62,55 | +0,97 % | Carl Zeiss Meditec-Aktie: Jetzt kaufen? | Die Aktie von Carl Zeiss Meditec (WKN: 157484) befindet sich nach dem Kursanstieg Ende September wieder im Abwärtstrend. Am Dienstag steht sie aktuell bei 63,20 €. Insgesamt ist sie sich in einer sehr... ► Artikel lesen | |
ECKERT & ZIEGLER | 43,900 | 0,00 % | DAX dank SAP im Plus - BMW, Deutsche Börse, Eckert & Ziegler, Ionos, SAP, Traton und Vonovia ... | Nach der Rekordfahrt in der Vorwoche hat der DAX zum Wochenstart eine Verschnaufpause eingelegt. Der deutsche Leitindex ging mit einem Minus von 196 Punkten oder exakt einem Prozent aus dem Handel,... ► Artikel lesen | |
TEMPUS AI | 45,290 | -2,66 % | Cathie Wood's ARK offloads Robinhood stock, buys Tempus AI | ||
ALIGNMENT HEALTHCARE | 10,600 | -1,49 % | Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells 30,000 Shares of Stock | ||
BOSTON SCIENTIFIC | 81,00 | -1,22 % | ROUNDUP: Boston Scientific Boosts FY24 Outlook | WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and sales growth... ► Artikel lesen | |
EUROFINS SCIENTIFIC | 47,310 | -1,21 % | Eurofins Scientific Stock: Robust Growth Amidst Market Challenges | ||
HIMS & HERS HEALTH | 19,580 | -10,39 % | Check Out What Whales Are Doing With HIMS | ||
PROCEPT BIOROBOTICS | 67,18 | -1,23 % | PROCEPT BioRobotics Co. (NASDAQ:PRCT) CFO Kevin Waters Sells 25,000 Shares | ||
UNITEDHEALTH | 524,10 | -0,74 % | Unitedhealth Aktie: Rekordumsatz trotz unerwarteter Herausforderungen | Der US-Krankenversicherer Unitedhealth verzeichnete im dritten Quartal 2023 einen beeindruckenden Umsatzanstieg von rund neun Prozent auf 100,8 Milliarden US-Dollar. Diese Zahl übertraf die durchschnittlichen... ► Artikel lesen | |
INTUITIVE SURGICAL | 474,80 | -0,94 % | Intuitive Surgical-Aktie: Einfach nicht zu bremsen | Die Intuitive Surgical-Aktie (WKN: 888024) ist seit Monaten nicht mehr zu bremsen. Wer das Papier des OP-Roboterherstellers vor einem Jahr kaufte, darf sich heute über einen Kursgewinn von fast +80%... ► Artikel lesen | |
PROGYNY | 15,865 | -1,64 % | Progyny, Inc. Announces Second Quarter 2024 Results | Achieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion RateBoard Authorizes Repurchase of $100 Million of Common Stock NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq:... ► Artikel lesen |